Puma Historical Financial Ratios

PBYI Stock

USD 3.14 0.12 3.97%

Puma Biotechnology is promptly reporting on over 108 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 2.22, Free Cash Flow Yield of 0.0739, Invested Capital of 0.0 or Operating Cash Flow Per Share of 0.6 will help investors to properly organize and evaluate Puma Biotechnology financial condition quickly.

Quick Ratio Current Ratio

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Puma Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For more detail on how to invest in Puma Stock please use our How to Invest in Puma Biotechnology guide.

About Puma Financial Ratios Analysis

Puma BiotechnologyFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Puma Biotechnology investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Puma financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Puma Biotechnology history.

Puma Biotechnology Financial Ratios Chart

As of now, Puma Biotechnology's Operating Cash Flow Per Share is increasing as compared to previous years. The Puma Biotechnology's current Average Payables is estimated to increase to about 268.7 K, while PTB Ratio is projected to decrease to 3.63.

Days Sales Outstanding Average Payables Inventory Turnover Days Of Inventory On Hand Cash Per Share

Add Fundamental

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Inventory Turnover

A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.

Most ratios from Puma Biotechnology's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Puma Biotechnology current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Puma Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For more detail on how to invest in Puma Stock please use our How to Invest in Puma Biotechnology guide.As of now, Puma Biotechnology's Operating Cash Flow Per Share is increasing as compared to previous years. The Puma Biotechnology's current Average Payables is estimated to increase to about 268.7 K, while PTB Ratio is projected to decrease to 3.63.

	2021	2022	2023	2024 (projected)
Payables Turnover	5.7	8.56	9.1	9.55
Days Of Inventory On Hand	40.73	29.98	41.23	52.69

Payables Turnover Days Of Inventory On Hand

Puma Biotechnology fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Average Payables	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe	Ev To Operating Cash Flow
Price To Sales Ratio		-0.6	-0.2	0.29	-0.09	-0.36	0.98	-0.95	-0.6	1.0	-0.37	0.58	0.2	-0.43	-0.21	0.17	0.89	0.49	0.23	0.92	0.08	0.53	-0.3	0.05	0.3	0.19
Ptb Ratio	-0.6		0.39	-0.17	-0.12	-0.04	-0.69	0.66	1.0	-0.59	-0.03	-0.96	-0.36	0.06	0.39	-0.3	-0.42	-0.38	-0.29	-0.65	-0.28	-0.19	0.39	0.24	-0.72	-0.3
Days Sales Outstanding	-0.2	0.39		0.67	-0.47	-0.68	-0.34	0.44	0.39	-0.17	-0.65	-0.39	-0.97	-0.48	0.98	-0.6	0.25	0.32	-0.47	-0.54	-0.36	-0.5	0.88	0.32	-0.45	-0.45
Book Value Per Share	0.29	-0.17	0.67		-0.5	-0.71	0.2	-0.13	-0.17	0.32	-0.64	0.16	-0.66	-0.65	0.67	-0.45	0.59	0.89	-0.31	-0.01	-0.28	-0.15	0.67	0.19	-0.16	-0.31
Free Cash Flow Yield	-0.09	-0.12	-0.47	-0.5		0.62	-0.03	-0.07	-0.12	-0.11	0.6	0.15	0.31	0.53	-0.44	0.44	-0.32	-0.48	-0.04	0.13	-0.09	0.22	-0.42	-0.27	0.32	-0.04
Operating Cash Flow Per Share	-0.36	-0.04	-0.68	-0.71	0.62		-0.25	0.09	-0.04	-0.39	0.99	0.12	0.65	0.94	-0.71	0.61	-0.69	-0.65	0.19	-0.05	0.19	0.14	-0.52	-0.09	0.29	0.2
Average Payables	0.98	-0.69	-0.34	0.2	-0.03	-0.25		-0.97	-0.69	0.98	-0.27	0.67	0.33	-0.34	-0.34	0.23	0.82	0.45	0.28	0.95	0.13	0.53	-0.41	-0.04	0.39	0.24
Capex To Depreciation	-0.95	0.66	0.44	-0.13	-0.07	0.09	-0.97		0.66	-0.94	0.09	-0.66	-0.43	0.18	0.45	-0.36	-0.73	-0.39	-0.3	-0.97	-0.14	-0.59	0.45	-0.02	-0.41	-0.26
Pb Ratio	-0.6	1.0	0.39	-0.17	-0.12	-0.04	-0.69	0.66		-0.59	-0.03	-0.96	-0.36	0.06	0.39	-0.3	-0.42	-0.38	-0.29	-0.65	-0.28	-0.19	0.39	0.24	-0.72	-0.3
Ev To Sales	1.0	-0.59	-0.17	0.32	-0.11	-0.39	0.98	-0.94	-0.59		-0.4	0.57	0.17	-0.45	-0.17	0.14	0.91	0.51	0.22	0.91	0.07	0.51	-0.27	0.05	0.28	0.18
Free Cash Flow Per Share	-0.37	-0.03	-0.65	-0.64	0.6	0.99	-0.27	0.09	-0.03	-0.4		0.12	0.62	0.93	-0.67	0.56	-0.68	-0.57	0.13	-0.07	0.14	0.1	-0.43	-0.1	0.28	0.15
Roic	0.58	-0.96	-0.39	0.16	0.15	0.12	0.67	-0.66	-0.96	0.57	0.12		0.39	0.04	-0.42	0.38	0.38	0.35	0.12	0.64	0.11	0.15	-0.38	-0.09	0.58	0.12
Inventory Turnover	0.2	-0.36	-0.97	-0.66	0.31	0.65	0.33	-0.43	-0.36	0.17	0.62	0.39		0.48	-0.98	0.62	-0.24	-0.32	0.43	0.53	0.33	0.46	-0.87	-0.19	0.36	0.42
Net Income Per Share	-0.43	0.06	-0.48	-0.65	0.53	0.94	-0.34	0.18	0.06	-0.45	0.93	0.04	0.48		-0.55	0.63	-0.68	-0.71	0.09	-0.16	0.11	0.03	-0.35	0.15	0.23	0.11
Days Of Inventory On Hand	-0.21	0.39	0.98	0.67	-0.44	-0.71	-0.34	0.45	0.39	-0.17	-0.67	-0.42	-0.98	-0.55		-0.74	0.25	0.37	-0.44	-0.55	-0.32	-0.54	0.91	0.15	-0.43	-0.42
Payables Turnover	0.17	-0.3	-0.6	-0.45	0.44	0.61	0.23	-0.36	-0.3	0.14	0.56	0.38	0.62	0.63	-0.74		-0.19	-0.44	0.18	0.44	0.06	0.56	-0.73	0.37	0.37	0.16
Capex To Revenue	0.89	-0.42	0.25	0.59	-0.32	-0.69	0.82	-0.73	-0.42	0.91	-0.68	0.38	-0.24	-0.68	0.25	-0.19		0.66	0.04	0.65	-0.05	0.26	0.12	0.1	0.09	0.01
Cash Per Share	0.49	-0.38	0.32	0.89	-0.48	-0.65	0.45	-0.39	-0.38	0.51	-0.57	0.35	-0.32	-0.71	0.37	-0.44	0.66		-0.12	0.26	-0.13	-0.01	0.42	-0.09	0.0	-0.12
Pocfratio	0.23	-0.29	-0.47	-0.31	-0.04	0.19	0.28	-0.3	-0.29	0.22	0.13	0.12	0.43	0.09	-0.44	0.18	0.04	-0.12		0.35	0.96	0.3	-0.41	-0.22	0.59	1.0
Interest Coverage	0.92	-0.65	-0.54	-0.01	0.13	-0.05	0.95	-0.97	-0.65	0.91	-0.07	0.64	0.53	-0.16	-0.55	0.44	0.65	0.26	0.35		0.18	0.65	-0.61	0.01	0.42	0.31
Capex To Operating Cash Flow	0.08	-0.28	-0.36	-0.28	-0.09	0.19	0.13	-0.14	-0.28	0.07	0.14	0.11	0.33	0.11	-0.32	0.06	-0.05	-0.13	0.96	0.18		0.02	-0.27	-0.23	0.59	0.97
Pfcf Ratio	0.53	-0.19	-0.5	-0.15	0.22	0.14	0.53	-0.59	-0.19	0.51	0.1	0.15	0.46	0.03	-0.54	0.56	0.26	-0.01	0.3	0.65	0.02		-0.63	0.09	0.15	0.25
Days Payables Outstanding	-0.3	0.39	0.88	0.67	-0.42	-0.52	-0.41	0.45	0.39	-0.27	-0.43	-0.38	-0.87	-0.35	0.91	-0.73	0.12	0.42	-0.41	-0.61	-0.27	-0.63		0.1	-0.37	-0.39
Income Quality	0.05	0.24	0.32	0.19	-0.27	-0.09	-0.04	-0.02	0.24	0.05	-0.1	-0.09	-0.19	0.15	0.15	0.37	0.1	-0.09	-0.22	0.01	-0.23	0.09	0.1		-0.39	-0.23
Roe	0.3	-0.72	-0.45	-0.16	0.32	0.29	0.39	-0.41	-0.72	0.28	0.28	0.58	0.36	0.23	-0.43	0.37	0.09	0.0	0.59	0.42	0.59	0.15	-0.37	-0.39		0.6
Ev To Operating Cash Flow	0.19	-0.3	-0.45	-0.31	-0.04	0.2	0.24	-0.26	-0.3	0.18	0.15	0.12	0.42	0.11	-0.42	0.16	0.01	-0.12	1.0	0.31	0.97	0.25	-0.39	-0.23	0.6

Click cells to compare fundamentals

Puma Biotechnology Account Relationship Matchups

Puma Biotechnology fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	1.25	1.8	0.49	0.83	0.87	0.91
Ptb Ratio	19.38	(67.68)	(51.48)	8.75	3.82	3.63
Days Sales Outstanding	38.73	41.42	46.89	64.6	75.11	66.96
Book Value Per Share	0.45	(0.15)	(0.0602)	0.48	1.13	2.22
Free Cash Flow Yield	0.0651	(0.0474)	0.17	(0.12)	0.0704	0.0739
Operating Cash Flow Per Share	0.58	0.0202	0.51	(0.35)	0.57	0.6
Stock Based Compensation To Revenue	0.21	0.16	0.13	0.0519	0.0435	0.0413
Capex To Depreciation	0.0825	0.0379	2.0	0.78	1.1	1.04
Pb Ratio	19.38	(67.68)	(51.48)	8.75	3.82	3.63
Ev To Sales	1.47	1.96	0.7	1.0	0.98	1.03
Free Cash Flow Per Share	0.57	(0.49)	0.51	(0.51)	0.3	0.32
Roic	(0.37)	(0.32)	(0.0915)	0.2	0.18	0.19
Inventory Turnover	11.61	11.41	8.96	12.17	8.85	7.88
Net Income Per Share	(2.13)	(1.52)	(0.72)	0.0204	0.46	0.48
Days Of Inventory On Hand	31.44	32.0	40.73	29.98	41.23	52.69
Payables Turnover	1.92	3.26	5.7	8.56	9.1	9.55
Sales General And Administrative To Revenue	0.52	0.53	0.46	0.39	0.38	0.36
Research And Ddevelopement To Revenue	0.49	0.43	0.28	0.23	0.21	0.2
Capex To Revenue	0.002426	0.001124	0.0891	0.0307	0.0536	0.0563
Cash Per Share	2.88	2.36	2.02	1.81	2.04	2.26
Pocfratio	15.14	507.56	5.97	(11.96)	7.56	7.93
Interest Coverage	(2.61)	(2.16)	(0.7)	2.06	2.45	2.57
Capex To Operating Cash Flow	(0.0253)	0.0137	25.06	(0.44)	0.47	0.44
Pfcf Ratio	15.35	(21.1)	5.97	(8.29)	14.2	14.91
Days Payables Outstanding	190.27	111.87	64.03	42.66	40.11	38.11
Income Quality	(0.3)	(0.0133)	(0.71)	1.25	1.44	1.51
Roe	(3.31)	(4.73)	12.13	0.0422	0.4	0.42
Ev To Operating Cash Flow	(33.84)	17.83	552.13	8.55	(14.37)	8.98
Pe Ratio	(4.1)	(6.77)	(4.25)	207.21	9.45	9.93
Return On Tangible Assets	(2.49)	(0.53)	(0.43)	(0.35)	0.006022	0.13
Ev To Free Cash Flow	18.08	(22.95)	8.55	(9.96)	16.08	16.88
Net Debt To E B I T D A	(1.08)	(0.93)	(9.92)	1.82	0.57	0.59
Current Ratio	3.02	1.83	1.28	1.73	1.57	1.49
Tangible Book Value Per Share	(0.59)	(2.02)	(1.69)	(1.1)	(0.16)	(0.15)
Receivables Turnover	9.42	8.81	7.78	5.65	4.86	7.99
Graham Number	4.66	2.27	0.98	0.47	3.42	3.25
Shareholders Equity Per Share	0.45	(0.15)	(0.0591)	0.48	1.13	2.1

Currently Active Assets on Macroaxis

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America
S	SentinelOne
WD	Walker Dunlop

When determining whether Puma Biotechnology offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Puma Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Puma Biotechnology Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Puma Biotechnology Stock:

How To Invest In Puma

Details

Is Puma Stock a good investment?

Details

What is Puma Biotechnology's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For more detail on how to invest in Puma Stock please use our How to Invest in Puma Biotechnology guide.

You can also try the Stocks Directory module to find actively traded stocks across global markets.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Puma Biotechnology. If investors know Puma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Puma Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

2.417

Earnings Share

0.47

Revenue Per Share

5.045

Quarterly Revenue Growth

0.435

Return On Assets

0.0973

The market value of Puma Biotechnology is measured differently than its book value, which is the value of Puma that is recorded on the company's balance sheet. Investors also form their own opinion of Puma Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Puma Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Puma Biotechnology's market value can be influenced by many factors that don't directly affect Puma Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Puma Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Puma Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Puma Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Puma Historical Financial Ratios

About Puma Financial Ratios Analysis

Puma Biotechnology Financial Ratios Chart

Average Payables

Inventory Turnover

Puma Biotechnology fundamentals Correlations

Puma Biotechnology Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Puma Biotechnology fundamentals Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ev To Sales	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Ev To Operating Cash Flow	+ 1.0	Pocfratio
Free Cash Flow Per Share	+ 0.99	Operating Cash Flow Per Share
Average Payables	+ 0.98	Price To Sales Ratio
Days Of Inventory On Hand	+ 0.98	Days Sales Outstanding

Days Of Inventory On Hand	- 0.98	Inventory Turnover
Interest Coverage	- 0.97	Capex To Depreciation
Capex To Depreciation	- 0.97	Average Payables
Inventory Turnover	- 0.97	Days Sales Outstanding
Roic	- 0.96	Pb Ratio
Roic	- 0.96	Ptb Ratio